» Articles » PMID: 7129819

Brominated Radiopaque Liposomes: Contrast Agent for Computed Tomography of Liver and Spleen: a Preliminary Report

Overview
Journal Invest Radiol
Specialty Radiology
Date 1982 Jul 1
PMID 7129819
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Contrast enhancement of liver and spleen in the dog was obtained after intravenous administration of brominated radioopaque liposomes (ROL) (1-5 micron in diameter. Computed tomographic (CT) numbers generated before and after 3 hours of ROL administration demonstrated an increase in hepatic attenuation. ROL are biodegradable lipid vesicles that can be subjected to further physicochemical modifications (size, charge composition) that alter their biodistribution and pharmacokinetics. These changes can result in improved hepatosplenic contrast enhancement.

Citing Articles

Gold-coated plant virus as computed tomography imaging contrast agent.

Aljabali A, Zoubi M, Al-Batanyeh K, Al-Radaideh A, Obeid M, Al Sharabi A Beilstein J Nanotechnol. 2019; 10:1983-1993.

PMID: 31667046 PMC: 6808194. DOI: 10.3762/bjnano.10.195.


Nanoparticle contrast agents for computed tomography: a focus on micelles.

Cormode D, Naha P, Fayad Z Contrast Media Mol Imaging. 2014; 9(1):37-52.

PMID: 24470293 PMC: 3905628. DOI: 10.1002/cmmi.1551.


Liposomes in drug delivery. Clinical, diagnostic and ophthalmic potential.

Gregoriadis G, Florence A Drugs. 1993; 45(1):15-28.

PMID: 7680982 DOI: 10.2165/00003495-199345010-00003.


Intraneoplastic application of metrizamide-containing liposomes: kinetic studies with computed tomography.

Wowra B, Cremer K, Stricker H, Zeller W J Neurooncol. 1992; 14(1):9-18.

PMID: 1469468 DOI: 10.1007/BF00170941.